Full Press Release Details
Medical To Present at the 8th Annual LD Micro Conference
Mont., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT: XTNT), formerly Bacterin International Holdings,
Inc., a leader in the development of class-leading regenerative medicine products and medical devices, today announced that its
Chief Executive Officer, Dan Goldberger and Chief Financial Officer, John Gandolfo will present at the 8th Annual LD Micro Main
Event, to be held December 1-3, 2015 at the Luxe Sunset Hotel in Los Angeles, CA. Xtant Medical's presentation will take place
Wednesday, December 2, 2015 at 8:00 AM Pacific Time.
live broadcast of the conference presentation will be available. To access the broadcast, go to the "Investor Info"
section of the Company's website at www.xtantmedical.com. A replay of the conference presentation will also be available.
Xtant Medical Holdings
Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets class-leading regenerative medicine products and medical
devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons,
including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease,
tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, foot and ankle surgeries.
With core competencies in both biologic and non-biologic surgical technologies, Xtant can leverage its resources to successfully
compete in global neurological and orthopedic surgery markets. For further information, please visit www.xtantmedical.com.
Cautions Regarding Forward-looking Statements
press release contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities
Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements
that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as "continue,"
"efforts," "expects," "anticipates," "intends," "plans," "believes,"
"estimates," "projects," "forecasts," "strategy," "will," "goal,"
"target," "prospects," "potential," "optimistic," "confident," "likely,"
"probable" or similar expressions or the negative thereof.
of historical fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve
risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among
others: the Company's ability to successfully integrate the acquisition of X-spine; the ability of the Company's sales force to
achieve expected results, the Company's ability to meet its existing and anticipated contractual obligations, including financial
covenant and other obligations contained in the Company's secured lending facility; the Company's ability to manage cash flow;
the Company's ability to develop, market, sell and distribute desirable applications, products and services and to protect its
intellectual property; the ability of the Company's customers to pay and the timeliness of such payments; the Company's ability
to obtain financing as and when needed; changes in consumer demands and preferences; the Company's ability to attract and retain
management and employees with appropriate skills and expertise; the impact of changes in market, legal and regulatory conditions
and in the applicable business environment, including actions of competitors; and other factors. Additional risk factors are listed
in the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q under the heading "Risk Factors." The
Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.